Dose-adjusted EPOCH-rituximab or intensified B-non-Hodgkin lymphoma therapy for pediatric primary mediastinal large B-cell lymphoma. Results from the study B-NHL-BFM-04 and the NHL-BFM registry 2012

Detalles Bibliográficos
Autores principales: Knörr, Fabian, Zimmermann, Martin, Attarbaschi, Andishe, Kabíčková, Edita, Maecker-Kolhoff, Britta, Ruf, Stephanie, Kühnle, Ingrid, Ebinger, Martin, Garthe, Anne-Kathrin, Simonitsch-Klupp, Ingrid, Oschlies, Ilske, Klapper, Wolfram, Burkhardt, Birgit, Woessmann, Wilhelm
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Fondazione Ferrata Storti 2021
Materias:
Letters to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8634171/
https://www.ncbi.nlm.nih.gov/pubmed/34498443
http://dx.doi.org/10.3324/haematol.2021.278971

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8634171/
https://www.ncbi.nlm.nih.gov/pubmed/34498443
http://dx.doi.org/10.3324/haematol.2021.278971

Ejemplares similares